FOXO4-DRI
- Category
- Longevity & Anti-Aging
- Administration routes
- Injectable
- Regulatory status
- Not FDA-approved
What it is
A D-retro-inverso senolytic peptide that clears senescent cells by blocking the FOXO4-p53 interaction so p53 can trigger their self-destruction. Selective clearance has moderate support, but broader anti-aging claims rest on weak rodent and cell data with no human pharmacokinetics. The chief concern is that it manipulates p53, a key tumor suppressor, and human safety remains unknown. Supply is unregulated research-grade peptide, not an approved drug in the US.
Read Full recordStudied uses & evidence
Studied uses(8)
Selective senescent cell clearance
MediumMultiple animal and cell studies show selective senescent-cell killing via a confirmed mechanism; no human trials.
Restoration of kidney function in aging
LowOne 2017 mouse study restored kidney markers like creatinine clearance in naturally aged animals.
Improved physical fitness and vitality in aged models
LowOne mouse study restored running capacity, coordination, and fur density across two aging models.
Evidence limits
- Evidence Level
- Preclinical
FOXO4-DRI has strong preclinical evidence from multiple independent labs across cell culture and animal studies, but no human clinical trials have been conducted. The original 2017 Cell paper demonstrated efficacy in three distinct mouse models (chemotoxicity, fast-aging, and natural aging). Subsequent studies have validated the approach in additional tissues including Leydig cells, chondrocytes, endothelial cells, and pulmonary fibroblasts. Second-generation variants with improved potency have been developed.
Benefits = confidence in the evidence: High · Medium · Low · Speculative (High requires human randomized trials for that specific benefit)
Cautions & risk summary
Do not use if
Active wound healing or surgery recovery
HighSenolytic action clears senescent cells needed for wound repair orchestration. May delay or impair healing.
Immune compromise
HighRapid clearance of senescent cells may overwhelm immune clearance capacity. Apoptotic debris can trigger secondary inflammation.
Active cancer (p53-dependent tumors)
ModerateModulates p53 nuclear localization. Effects on p53-dependent tumor suppression are complex and unpredictable.
General cautions
Pregnancy
AbsoluteInducing apoptosis of senescent cells during pregnancy could be extremely harmful to fetal development.
Risk summary(6)
Risks = level of concern: High · Moderate · Low · Theoretical
All safety data from rodent studies and cell culture; no human pharmacokinetics
HighDisrupts p53 dynamics; p53 is a critical tumor suppressor
ModerateHuman dosing extrapolated from mouse studies
ModerateInjection site reactions
LowFull spectrum of affected tissues not characterized
ModerateUnregulated products sold online; quality varies
High
Further reading
- Overview in Full record
- Safety & interactions in Full record
- Research & benefits in Full record
- Regulation & availability in Full record
- Sources in Full record
- Frequently asked questions in Full record
This is educational content compiled from published research, not medical advice. Always consult a licensed healthcare provider before using any peptide. Medical disclaimer
Compiled from published research indexed through March 2026.